International Congress Munich 2014

Saturday, 06.09.2014 Sunday, 07.09.2014 Monday, 08.09.2014 Tuesday, 09.09.2014 Wednesday, 10.09.2014		Sponsored symposia: Boehringer Ingelheim Evening Symposium: "Identifying the unmet needs in asthma: Who, why and how many?" Bayer Expert Forum: “Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in Non-CF Bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.

Pathways to personalised medicine in obstructive lung disease

Hot topics
Chairs: D. Meyers (Winston-Salem, United States of America), P. Howarth (Southampton, United Kingdom)
Aims: The aims of this Hot Topic are to provide an understanding of the following:
- Disease heterogeneity and subpopulations in both asthma and COPD, and their importance in targeted treatments;
- The role of genetics and genetic risk scores in determining disease susceptibility and severity (genome-wide sequencing is now a reality);
- The clinical application of biomarkers such as genetic risk profiles and imaging to personalised treatment; and,
- The usefulness and applicability of pharmacogenetics to personalised therapies.

Download all media

Asthma heterogeneity and sub-phenotypes M. Gaga (Athens, Greece)
COPD heterogeneity and sub-phenotypes J. Vestbo (Hellerup, Denmark)
COPD prediction by using imaging and genetic profiles P. Castaldi (Boston, United States of America)